Cite

HARVARD Citation

    Dings, M. et al. (2023). Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer. International journal of cancer. 152 (3), pp. 511-523. [Online]. 
  
Back to record